Report Detail
Covid-19 Impact on Patient Identity Resolution Software Market, Global Research Reports 2020-2021
- RnM3973463 |
- 20 May, 2020 |
- Global |
- 127 Pages |
- XYZResearch |
- Other
Patient identity resolution software—also referred to as healthcare identity resolution, enterprise master patient index (EMPI), or patient identity management software—facilitates the creation of a single, holistic record view of each patient. Hospital or clinic staff and health care administrators can use patient identity resolution software to deduplicate medical records, minimize errors in patient records, and improve clinical processes. The software pulls patient information from electronic health records (EHRs), hospital systems, pharmacies, and other consumer data sources to coordinate patient data across the health care ecosystem.
This report provides a complete quantitative data and qualitative analysis on the global market for Patient Identity Resolution Software. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Patient Identity Resolution Software was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Patient Identity Resolution Software is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Patient Identity Resolution Software, including the following market information:
Global Patient Identity Resolution Software Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Patient Identity Resolution Software Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Patient Identity Resolution Software Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Patient Identity Resolution Software Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include LexisNexis, Imprivata, 4medica, Acxiom, Avatier, Civica, Data Ladder, Experian, Beta Systems IAM Software AG, Health Catalyst, HealthVerity, Black Oak Analytics, InDxLogic, Informatica, ARGO, InterSystems, NextGate, NetOwl, Occam, One Identity, Custodix, QuadraMed Healthcare Identity Experts, RightPatient, SBS Superior Business Solutions, Optimal IdM, Verato, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Cloud-Based
Web-Based
Based on the Application:
Hospital
Client
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Patient Identity Resolution Software Quarterly Market Size Analysis
- 2.1 Patient Identity Resolution Software Business Impact Assessment - COVID-19
- 2.1.1 Global Patient Identity Resolution Software Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Patient Identity Resolution Software Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Patient Identity Resolution Software Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Patient Identity Resolution Software Headquarters and Area Served
- 3.3 Date of Key Players Enter into Patient Identity Resolution Software Market
- 3.4 Key Players Patient Identity Resolution Software Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Patient Identity Resolution Software Segments, By Type
- 4.1 Introduction
- 1.4.1 Cloud-Based
- 1.4.2 Web-Based
- 4.2 By Type, Global Patient Identity Resolution Software Market Size, 2019-2021
5 Impact of Covid-19 on Patient Identity Resolution Software Segments, By Application
- 5.1 Overview
- 5.5.1 Hospital
- 5.5.2 Client
- 5.2 By Application, Global Patient Identity Resolution Software Market Size, 2019-2021
- 5.2.1 By Application, Global Patient Identity Resolution Software Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 LexisNexis
- 7.1.1 LexisNexis Business Overview
- 7.1.2 LexisNexis Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.1.3 LexisNexis Patient Identity Resolution Software Product Introduction
- 7.1.4 LexisNexis Response to COVID-19 and Related Developments
- 7.2 Imprivata
- 7.2.1 Imprivata Business Overview
- 7.2.2 Imprivata Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.2.3 Imprivata Patient Identity Resolution Software Product Introduction
- 7.2.4 Imprivata Response to COVID-19 and Related Developments
- 7.3 4medica
- 7.3.1 4medica Business Overview
- 7.3.2 4medica Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.3.3 4medica Patient Identity Resolution Software Product Introduction
- 7.3.4 4medica Response to COVID-19 and Related Developments
- 7.4 Acxiom
- 7.4.1 Acxiom Business Overview
- 7.4.2 Acxiom Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.4.3 Acxiom Patient Identity Resolution Software Product Introduction
- 7.4.4 Acxiom Response to COVID-19 and Related Developments
- 7.5 Avatier
- 7.5.1 Avatier Business Overview
- 7.5.2 Avatier Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.5.3 Avatier Patient Identity Resolution Software Product Introduction
- 7.5.4 Avatier Response to COVID-19 and Related Developments
- 7.6 Civica
- 7.6.1 Civica Business Overview
- 7.6.2 Civica Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.6.3 Civica Patient Identity Resolution Software Product Introduction
- 7.6.4 Civica Response to COVID-19 and Related Developments
- 7.7 Data Ladder
- 7.7.1 Data Ladder Business Overview
- 7.7.2 Data Ladder Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.7.3 Data Ladder Patient Identity Resolution Software Product Introduction
- 7.7.4 Data Ladder Response to COVID-19 and Related Developments
- 7.8 Experian
- 7.8.1 Experian Business Overview
- 7.8.2 Experian Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.8.3 Experian Patient Identity Resolution Software Product Introduction
- 7.8.4 Experian Response to COVID-19 and Related Developments
- 7.9 Beta Systems IAM Software AG
- 7.9.1 Beta Systems IAM Software AG Business Overview
- 7.9.2 Beta Systems IAM Software AG Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.9.3 Beta Systems IAM Software AG Patient Identity Resolution Software Product Introduction
- 7.9.4 Beta Systems IAM Software AG Response to COVID-19 and Related Developments
- 7.10 Health Catalyst
- 7.10.1 Health Catalyst Business Overview
- 7.10.2 Health Catalyst Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.10.3 Health Catalyst Patient Identity Resolution Software Product Introduction
- 7.10.4 Health Catalyst Response to COVID-19 and Related Developments
- 7.11 HealthVerity
- 7.11.1 HealthVerity Business Overview
- 7.11.2 HealthVerity Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.11.3 HealthVerity Patient Identity Resolution Software Product Introduction
- 7.11.4 HealthVerity Response to COVID-19 and Related Developments
- 7.12 Black Oak Analytics
- 7.12.1 Black Oak Analytics Business Overview
- 7.12.2 Black Oak Analytics Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.12.3 Black Oak Analytics Patient Identity Resolution Software Product Introduction
- 7.12.4 Black Oak Analytics Response to COVID-19 and Related Developments
- 7.13 InDxLogic
- 7.13.1 InDxLogic Business Overview
- 7.13.2 InDxLogic Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.13.3 InDxLogic Patient Identity Resolution Software Product Introduction
- 7.13.4 InDxLogic Response to COVID-19 and Related Developments
- 7.14 Informatica
- 7.14.1 Informatica Business Overview
- 7.14.2 Informatica Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.14.3 Informatica Patient Identity Resolution Software Product Introduction
- 7.14.4 Informatica Response to COVID-19 and Related Developments
- 7.15 ARGO
- 7.15.1 ARGO Business Overview
- 7.15.2 ARGO Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.15.3 ARGO Patient Identity Resolution Software Product Introduction
- 7.15.4 ARGO Response to COVID-19 and Related Developments
- 7.16 InterSystems
- 7.16.1 InterSystems Business Overview
- 7.16.2 InterSystems Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.16.3 InterSystems Patient Identity Resolution Software Product Introduction
- 7.16.4 InterSystems Response to COVID-19 and Related Developments
- 7.17 NextGate
- 7.17.1 NextGate Business Overview
- 7.17.2 NextGate Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.17.3 NextGate Patient Identity Resolution Software Product Introduction
- 7.17.4 NextGate Response to COVID-19 and Related Developments
- 7.18 NetOwl
- 7.18.1 NetOwl Business Overview
- 7.18.2 NetOwl Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.18.3 NetOwl Patient Identity Resolution Software Product Introduction
- 7.18.4 NetOwl Response to COVID-19 and Related Developments
- 7.19 Occam
- 7.19.1 Occam Business Overview
- 7.19.2 Occam Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.19.3 Occam Patient Identity Resolution Software Product Introduction
- 7.19.4 Occam Response to COVID-19 and Related Developments
- 7.20 One Identity
- 7.20.1 One Identity Business Overview
- 7.20.2 One Identity Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.20.3 One Identity Patient Identity Resolution Software Product Introduction
- 7.20.4 One Identity Response to COVID-19 and Related Developments
- 7.21 Custodix
- 7.21.1 Custodix Business Overview
- 7.21.2 Custodix Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.21.3 Custodix Patient Identity Resolution Software Product Introduction
- 7.21.4 Custodix Response to COVID-19 and Related Developments
- 7.22 QuadraMed Healthcare Identity Experts
- 7.22.1 QuadraMed Healthcare Identity Experts Business Overview
- 7.22.2 QuadraMed Healthcare Identity Experts Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.22.3 QuadraMed Healthcare Identity Experts Patient Identity Resolution Software Product Introduction
- 7.22.4 QuadraMed Healthcare Identity Experts Response to COVID-19 and Related Developments
- 7.23 RightPatient
- 7.23.1 RightPatient Business Overview
- 7.23.2 RightPatient Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.23.3 RightPatient Patient Identity Resolution Software Product Introduction
- 7.23.4 RightPatient Response to COVID-19 and Related Developments
- 7.24 SBS Superior Business Solutions
- 7.24.1 SBS Superior Business Solutions Business Overview
- 7.24.2 SBS Superior Business Solutions Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.24.3 SBS Superior Business Solutions Patient Identity Resolution Software Product Introduction
- 7.24.4 SBS Superior Business Solutions Response to COVID-19 and Related Developments
- 7.25 Optimal IdM
- 7.25.1 Optimal IdM Business Overview
- 7.25.2 Optimal IdM Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.25.3 Optimal IdM Patient Identity Resolution Software Product Introduction
- 7.25.4 Optimal IdM Response to COVID-19 and Related Developments
- 7.26 Verato
- 7.26.1 Verato Business Overview
- 7.26.2 Verato Patient Identity Resolution Software Quarterly Revenue, 2020
- 7.26.3 Verato Patient Identity Resolution Software Product Introduction
- 7.26.4 Verato Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
Summary:
Get latest Market Research Reports on Patient Identity Resolution Software. Industry analysis & Market Report on Patient Identity Resolution Software is a syndicated market report, published as Covid-19 Impact on Patient Identity Resolution Software Market, Global Research Reports 2020-2021. It is complete Research Study and Industry Analysis of Patient Identity Resolution Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
